Court restricts abortion access across US by blocking mailing of mifepristone
abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
- Appeals court halts mail and telehealth access (4)
- Clinical pivots and drug alternatives amid disruptions (3)
- Supreme Court temporarily restores mail access (5)
- All Other Stories
Appeals court halts mail and telehealth access
Clinical pivots and drug alternatives amid disruptions
Supreme Court temporarily restores mail access
All Other Stories
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
FDA updates mifepristone safety review, but pharmacies remain reluctant / 6 wks
Telehealth abortion pills rise as teens drive online demand / 2 months
Supreme Court preserves telehealth and mail access to abortion pill / 16 days
FDA weighs easing access to compounded peptides for patients / 6 wks
New women's health plan draws criticism for ignoring women's voices / 6 wks
FDA to Remove Black Box Warnings from Menopausal Hormone Therapies / 6 months
FDA commissioner Marty Makary resigns amid mounting scrutiny / 19 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try None, Pharmaceuticals, Digital Health, Drug Development and look for the RSS link.
StackHealth Time Machine